Disco Pharmaceuticals Gmbh logo
VerifiedPharmaceutical Manufacturing· Founded 2022

Disco Pharmaceuticals Gmbh

DISCO’s pioneering surfaceome mapping platform transforms the current approach of target discovery for large molecule R&D. The technology identifies proteins and protein communities across the entire cancer cell surface in a scalable manner, thus addressing the need for target candidates for both mono- and bi-specific antibodies. These insights enable the development of a multitude of cancer-selective therapies, with the potential to boost efficacy and reducing side effects for patients.

7-day free trial · no credit card

HeadquartersCologne, GermanyEmployees38(11 to 50)Founded year2022Websitediscopharma.deLinkedIn profileLinkedIn

Verified contacts

23

available on Kipplo

LinkedIn employees

38

11 to 50 range

Open roles

—

no listings

Distinct roles

14

indexed titles

Tech stack

0

tools in use

Monthly traffic

—

organic / mo

Sign up free to see all 23 verified contacts at Disco Pharmaceuticals Gmbh

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

23 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Disco Pharmaceuticals Gmbh

14 distinct titles indexed · top 10 shown.

  • 5research associate
  • 2bta
  • 2project leader
  • 2scientist - cell surface proteomics
  • 1administration assistant
  • 1assistent der geschäftsleitung
  • 1chief business officer
  • 1chief operating officer (coo) and founder
  • 1executive assistant
  • 1ikena oncology
  • +4more titles

Sign up to unlock all 23 contacts at Disco Pharmaceuticals Gmbh

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 23 verified contacts at Disco Pharmaceuticals Gmbh

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Disco Pharmaceuticals Gmbh | Kipplo Discover